Evidence map›Paper›PMID 32273145›Full record

ReviewPatient education and counseling2020

Patients' understanding of oncology clinical endpoints: A literature review.

Vanessa Boudewyns, Brian G Southwell, Jessica T DeFrank, Kate Ferriola-Bruckenstein, Michael T Halpern, Amie C O'Donoghue, Helen W Sullivan

Abstract readReview
In one paragraph

Review in Patient education and counseling, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Cancer Survivors' and Caregivers' Understanding of FDA Accelerated Approval Disclosures.Journal of cancer education : the official journal of the American Association for Cancer Education · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Vanessa BoudewynsRTI International, Research Triangle Park, NC, USA.
Brian G SouthwellRTI International, Research Triangle Park, NC, USA.
Jessica T DeFrankRTI International, Research Triangle Park, NC, USA.
Kate Ferriola-BruckensteinRTI International, Research Triangle Park, NC, USA.
Michael T HalpernRTI International, Research Triangle Park, NC, USA.
Amie C O'DonoghueUS Food and Drug Administration, Silver Spring, MD, USA.
Helen W SullivanUS Food and Drug Administration, Silver Spring, MD, USA. Electronic address: Helen.sullivan@fda.hhs.gov.

Funding

Intramural FDA HHS FD999999
6 · The paper itself

Abstract

objectivesOncology clinical trials use a variety of clinical endpoints. Patients' understanding of the differences between clinical endpoints is important because misperceptions of treatment efficacy may affect treatment decisions. The objective of this literature review is to find and synthesize available empirical publications assessing patients' understanding of common oncology clinical endpoints.

methodsWe conducted a literature search of 5 databases and 3 conferences, limiting the search to articles and abstracts published in English through September 2018. We reviewed the titles and abstracts for inclusion, then reviewed full texts to determine if they reported empirical research studies focused on (1) clinical endpoints, (2) oncology, and (3) patient understanding. The original search identified 497publications, of which 13 met the inclusion criteria.

resultsAvailable literature yields little information on this topic.The few publications that do exist suggest that healthcare professionals and cancer patients generally do not discuss clinical endpoint concepts and that patients can be confused about the purpose of a treatment based on misperceptions about endpoints.

conclusionsResearch is needed on how to discuss oncology clinical endpoints with patients. PRACTICE IMPLICATIONS: Patient-friendly definitions of clinical endpoints may help healthcare providers communicate important information about treatments to patients.

Indexed as

Endpoint DeterminationMedical OncologyClinical Trials as TopicComprehensionDisease-Free SurvivalHumansNeoplasmsPatient Education as TopicPatientsClinical endpointsPatientsPatient understandingProgression-free survivalRegulatory science

Identifiers

PMID32273145
PMCPMC7423743

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.